Preparation and physicochemical characterization of naproxen-PLGA nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 81, Issue 2, 2010, Pages 498-502

  Javadzadeh, Yousef ^a,b   Ahadi, Fatemeh ^a   Davaran, Soodabeh ^a   Mohammadi, Ghobad ^a,c   Sabzevari, Araz ^d   Adibkia, Khosro ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nanoparticles; Naproxen; Physicochemical characteristics; PLGA; Solvent evaporation

Indexed keywords

ANTI-INFLAMMATORY EFFECTS; AQUEOUS PHASE; CHEMICAL INTERACTIONS; CRYSTALLINITIES; INFLAMMATORY DISORDERS; NAPROXENS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHYSICAL MIXTURES; PHYSICO-CHEMICAL CHARACTERIZATION; PHYSICOCHEMICAL CHARACTERISTICS; PLGA; PLGA NANOPARTICLES; POLYMER MOLECULE; PREPARATION CONDITIONS; PROCESS PARAMETERS; RELEASE RATE; SOLVENT EVAPORATION;

DIFFERENTIAL SCANNING CALORIMETRY; DRUG INTERACTIONS; EMULSIFICATION; EVAPORATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SOLVENTS; X RAY CRYSTALLOGRAPHY;

NANOPARTICLES;

NANOPARTICLE; NAPROXEN; POLYGLACTIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; EVAPORATION; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; X RAY CRYSTALLOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHYSICAL; LACTIC ACID; NAPROXEN; PARTICLE SIZE; POLYGLYCOLIC ACID; POWDER DIFFRACTION; SURFACE PROPERTIES; TEMPERATURE; TIME FACTORS;

EID: 77956649137     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.07.047     Document Type: Article

References (34)

1. Farokhzad O.C., Langer R. ACS Nano 2009, 3:16-20.
2. Lavan D.A., McGuire T., Langer R. Nat. Biotechnol. 2003, 21:1184-1191.
3. Whitesides G.M. Nat. Biotechnol. 2003, 21:1161-1165.
4. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Clin. Pharmacol. Ther. 2007.
5. Langer R. Science 1990, 249:1527-1533.
6. Langer R. Nature 1998, 392:5-10.
7. Mi F.L., Shyu S.S., Lin Y.M., Wu Y.B., Peng C.K., Tsai Y.H. Biomaterials 2003, 24:5023-5036.
8. Sturesson C., Carlfors J. J. Control. Release 2000, 67:171-178.
9. Rodrigues M.R., Lanzarini C.M., Ricci-Junior E. Pharm. Dev. Technol. 2009.
10. Wiseman H.L., Chang Y.H., Lombardino J.G. Arznneim. Forsch. Drug Res. 1976, 26:1300-1303.
11. Gieldanowski J. Arch. Immunol. Ther. Exp. (Warsz.) 1988, 36:229-237.
12. Maudgal P.C., Cornelis H., Missotten L. Graefe's Arch. Ophthalmol. 1989, 216:191-194.
13. Bernstein H.N., Schwartz Z.B. Arch. Ophthalmol. 1962, 68:742-753.
14. Michelle L., Reichle O.D. J. Am. Optom. Assoc. 2005, 76:450-460.
15. Ganem-Quintanar A., Silva-Alvarez M., varez-Roman R., Casas-Alancaster N., Cazares-Delgadillo J., Quintanar-Guerrero D. J. Nanosci. Nanotechnol. 2006, 6:3235-3241.
16. Bucolo C., Maltese A., Maugeri F., Busa B., Puglisi G., Pignatello R. J. Pharm. Pharmacol. 2004, 56:841-846.
17. Pignatello R., Bucolo C., Ferrara P., Maltese A., Puleo A., Puglisi G. Eur. J. Pharm. Sci. 2002, 16:53-61.
18. Jain R.A. Biomaterials 2000, 21:2475-2490.
19. Adibkia K., Omidi Y., Siahi M.R., Javadzadeh A.R., Barzegar-Jalali M., Barar J., Maleki N., Mohammadi G., Nokhodchi A. J. Ocul. Pharmacol. Ther. 2007, 23:421-432.
20. Adibkia K., Siahi Shadbad M.R., Nokhodchi A., Javadzedeh A., Barzegar-Jalali M., Barar J., Mohammadi G., Omidi Y. J. Drug Target 2007, 15:407-416.
21. Kopade A.J., Jain N.K. Pharmazie 1995, 50:812-814.
22. Kawashima Y., Niwa T., Handa T., Takeuchi H., Iwamoto T., Itoh K. J. Pharm. Sci. 1989, 78:68-72.
23. Mainardes R.M., Evangelista R.C. Int. J. Pharm. 2005, 290:137-144.
24. Murakami H., Kobayashi M., Takeuchi H., Kawashima Y. Int. J. Pharm. 1999, 187:143-152.
25. Chorny M., Fishbein I., Danenberg H.D., Golomb G. J. Control. Release 2002, 83:389-400.
26. Mura P., Bettinetti G.P., Cirri M., Maestrelli F., Sorrenti M., Catenacci L. Eur. J. Pharm. Biopharm. 2005, 59:99-106.
27. Mura P., Faucci M.T., Bettinetti G.P. Eur. J. Pharm. Sci. 2001, 13:187-194.
28. Tiong N., Elkordy A.A. Eur. J. Pharm. Biopharm. 2009, 73:373-384.
29. Bhise K.S., Dhumal R.S., Paradkar A.R., Kadam S.S. AAPS PharmSciTech 2008, 9:1-12.
30. Zaghloul A.A., Mustafa F., Siddiqu A., Khan M. Drug Dev. Ind. Pharm. 2005, 31:803-811.
31. Douglas S.J., Davis S.S., Illum L. Crit. Rev. Ther. Drug Carrier Syst. 1987, 3:233-261.
32. Leo E., Forni F., Bernabei M.T. Int. J. Pharm. 2000, 196:1-9.
33. Kim D.H., Martin D.C. Biomaterials 2006, 27:3031-3037.
34. Bhaskar K., Anbu J., Ravichandiran V., Venkateswarlu V., Rao Y.M. Lipids Health Dis. 2009, 8:6.